{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:52:35Z","timestamp":1773924755896,"version":"3.50.1"},"reference-count":54,"publisher":"FapUNIFESP (SciELO)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mem. Inst. Oswaldo Cruz"],"DOI":"10.1590\/0074-02760180050","type":"journal-article","created":{"date-parts":[[2018,5,5]],"date-time":"2018-05-05T19:16:42Z","timestamp":1525547802000},"source":"Crossref","is-referenced-by-count":7,"title":["Diagnostic and therapeutic strategies in cryptococcosis: impact on outcome"],"prefix":"10.1590","volume":"113","author":[{"given":"Timoth\u00e9e Boyer","family":"Chammard","sequence":"first","affiliation":[{"name":"Institut Pasteur, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elvis","family":"Temfack","sequence":"additional","affiliation":[{"name":"Douala General Hospital, Cameroon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Lortholary","sequence":"additional","affiliation":[{"name":"Institut Pasteur, France; University Paris Descartes, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Alanio","sequence":"additional","affiliation":[{"name":"Institut Pasteur, France; University Paris Diderot, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2018,5,7]]},"reference":[{"issue":"8","key":"ref1","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/bmt.2011.246","article-title":"ECIL-3 classical diagnostic procedures for the diagnosis of invasive fungal diseases in patients with leukaemia","volume":"47","author":"Arendrup MC","year":"2012","journal-title":"Bone Marrow Transplant."},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1056\/NEJMoa1509024","article-title":"Adjunctive dexamethasone in HIV-associated cryptococcal meningitis","volume":"374","author":"Beardsley J","year":"2016","journal-title":"N Engl J Med."},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1056\/NEJM197907193010303","article-title":"A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis","volume":"19301","author":"Bennett JE","year":"1979","journal-title":"N Engl J Med."},{"key":"ref4","first-page":"1","article-title":"Inadequacy of high-dose fluconazole monotherapy among cerebrospinal fluid cryptococcal antigen (CrAg)-positive human immunodeficiency virus-infected persons in an Ethiopian CrAg screening program","volume":"17","author":"Beyene T","year":"2017","journal-title":"Clin Infect Dis."},{"issue":"12","key":"ref5","doi-asserted-by":"crossref","first-page":"7224","DOI":"10.1128\/AAC.01698-15","article-title":"Toxicity of amphotericin B deoxycholate-based induction therapy in patients with HIV-associated cryptococcal meningitis","volume":"59","author":"Bicanic T","year":"2015","journal-title":"Antimicrob Agents Chemother."},{"issue":"6","key":"ref6","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/QAD.0b013e32832605fe","article-title":"Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures","volume":"2723","author":"Bicanic T","year":"2009","journal-title":"AIDS."},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1086\/518607","article-title":"Fungal burden, early fungicidal activity, and outcome in crypto-coccal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole","volume":"145","author":"Bicanic T","year":"2007","journal-title":"Clin Infect Dis."},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1086\/604716","article-title":"Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients","volume":"149","author":"Bicanic T","year":"2009","journal-title":"Clin Infect Dis."},{"issue":"26","key":"ref9","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMoa1312884","article-title":"Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis","volume":"26370","author":"Boulware DR","year":"2014","journal-title":"N Engl J Med."},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3201\/eid2001.130906","article-title":"Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast","volume":"20","author":"Boulware DR","year":"2014","journal-title":"Emerg Infect Dis."},{"issue":"9423","key":"ref11","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(04)16301-0","article-title":"Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial","volume":"29363","author":"Brouwer AE","year":"2004","journal-title":"Lancet."},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1086\/432073","article-title":"Baseline correlation and comparative kinetics of cerebrospinal fluid colony-forming unit counts and antigen titers in cryptococcal meningitis","volume":"15192","author":"Brouwer AE","year":"2005","journal-title":"J Infect Dis."},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00765-13","article-title":"Estrogen receptor antagonists are anti-cryptococcal agents that directly bind EF hand proteins and synergize with fluconazole in vivo","volume":"115","author":"Butts A","year":"2014","journal-title":"MBio."},{"issue":"14","key":"ref14","first-page":"1291","article-title":"Combination antifungal therapy for cryptococcal meningitis","volume":"4368","author":"Day JN","year":"2013","journal-title":"N Engl J Med."},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00002030-198902000-00004","article-title":"The value of cryptococcal serum antigen screening among HIV-positive\/AIDS patients in Kinshasa, Zaire","volume":"3","author":"Desmet P","year":"1989","journal-title":"AIDS"},{"issue":"8","key":"ref16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002870","article-title":"Major role for amphotericin B-flucytosine combination in severe cryptococcosis","volume":"3","author":"Dromer F","year":"2008","journal-title":"PLoS One"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1371\/journal.pmed.0040021","article-title":"Determinants of disease presentation and outcome during cryptococcosis: the CryptoA\/D study","volume":"4","author":"Dromer F","year":"2007","journal-title":"PLoS Med"},{"issue":"7","key":"ref18","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/00002030-200205030-00009","article-title":"Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults","volume":"316","author":"French N","year":"2002","journal-title":"AIDS."},{"issue":"11","key":"ref19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110285","article-title":"A prospective study of mortality from cryptococcal meningitis following treatment induction with 1200 mg oral fluconazole in Blantyre, Malawi","volume":"9","author":"Gaskell KM","year":"2014","journal-title":"PLoS ONE."},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1086\/313603","article-title":"Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups","volume":"30","author":"Graybill JR","year":"2000","journal-title":"Clin Infect Dis."},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1086\/653606","article-title":"Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS-associated acute cryptococcal meningitis: a randomized, double-blind clinical trial of efficacy and safety","volume":"1551","author":"Hamill RJ","year":"2010","journal-title":"Clin Infect Dis."},{"issue":"7","key":"ref22","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1086\/597262","article-title":"Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa","volume":"48","author":"Jarvis JN","year":"2009","journal-title":"Clin Infect Dis."},{"key":"ref23","author":"Jarvis JN","year":"2017"},{"issue":"9","key":"ref24","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/QAD.0b013e3283536a93","article-title":"Adjunctive interferon-\u03b3 immunotherapy for the treatment of HIV-associated cryptococcal meningitis","volume":"26","author":"Jarvis JN","year":"2012","journal-title":"AIDS."},{"issue":"11","key":"ref25","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1086\/587667","article-title":"Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy","volume":"46","author":"Kambugu A","year":"2008","journal-title":"Clin Infect Dis."},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1128\/AAC.00990-07","article-title":"Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis","volume":"2352","author":"Kontoyiannis DP","year":"2008","journal-title":"Antimicrob Agents Chemother."},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/clinids\/19.4.741","article-title":"Fluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDS","volume":"19","author":"Larsen RA","year":"1994","journal-title":"Clin Infect Dis."},{"issue":"12","key":"ref28","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/00002030-199712000-00010","article-title":"Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis","volume":"11","author":"Leenders AC","year":"1997","journal-title":"AIDS."},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofv046","article-title":"Cryptococcal antigenemia in immunocompromised human immunodeficiency virus patients in rural Tanzania: a preventable cause of early mortality","volume":"22","author":"Letang E","year":"2015","journal-title":"Open Forum Infect Dis."},{"issue":"5","key":"ref30","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/cid\/civ936","article-title":"Cryptococcal antigen screening in patients initiating ART in South Africa: a prospective cohort study","volume":"162","author":"Longley N","year":"2016","journal-title":"Clin Infect Dis."},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/cid\/cir745","article-title":"Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis","volume":"154","author":"Loyse A","year":"2012","journal-title":"Clin Infect Dis."},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s40475-015-0045-z","article-title":"Preventing cryptococcosis - Shifting the paradigm in the era of highly active antiretroviral therapy","volume":"212","author":"Meya D","year":"2015","journal-title":"Curr Trop Med Rep."},{"issue":"9983","key":"ref33","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/S0140-6736(15)60164-7","article-title":"Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial","volume":"30385","author":"Mfinanga S","year":"2015","journal-title":"Lancet."},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s13063-015-0799-6","article-title":"AMBITION-cm: intermittent high dose AmBisome on a high dose fluconazole backbone for cryptococcal meningitis induction therapy in sub-Saharan Africa: study protocol for a randomized controlled trial","volume":"1716","author":"Molefi M","year":"2015","journal-title":"Trials."},{"issue":"11","key":"ref35","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJMoa1710922","article-title":"Antifungal combinations for treatment of cryptococcal meningitis in Africa","volume":"378","author":"Molloy SF","year":"2018","journal-title":"N Engl J Med."},{"issue":"8","key":"ref36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159727","article-title":"Early fungicidal activity as a candidate surrogate endpoint for all-cause mortality in cryptococcal meningitis: a systematic review of the evidence","volume":"11","author":"Montezuma-Rusca JM","year":"2016","journal-title":"PLoS One."},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jinf.2011.10.014","article-title":"Short course amphotericin B with high dose fluconazole for HIV-associated cryptococcal meningitis","volume":"64","author":"Muzoora CK","year":"2012","journal-title":"J Infect."},{"issue":"6","key":"ref38","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1086\/342299","article-title":"A randomized, double-blind, placebo-controlled trial of acetazolamide for the treatment of elevated intracranial pressure in cryptococcal meningitis","volume":"35","author":"Newton PN","year":"2002","journal-title":"Clin Infect Dis."},{"issue":"3","key":"ref39","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1086\/649861","article-title":"Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in malawi","volume":"50","author":"Nussbaum JC","year":"2010","journal-title":"Clin Infect Dis."},{"issue":"12","key":"ref40","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1086\/599112","article-title":"A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis","volume":"48","author":"Pappas PG","year":"2009","journal-title":"Clin Infect Dis."},{"issue":"3","key":"ref41","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical Practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America","volume":"50","author":"Perfect JR","year":"2010","journal-title":"Clin Infect Dis."},{"key":"ref42","author":"Rhein J","year":"2018"},{"issue":"7","key":"ref43","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S1473-3099(16)00074-8","article-title":"Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study","volume":"16","author":"Rhein J","year":"2016","journal-title":"Lancet Infect Dis."},{"issue":"11","key":"ref44","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/cid\/ciu596","article-title":"The Effect of therapeutic lumbar punctures on acute mortality from cryptococcal meningitis","volume":"59","author":"Rolfes MA","year":"2014","journal-title":"Clin Infect Dis."},{"issue":"6","key":"ref45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067311","article-title":"A prospective longitudinal study of the clinical outcomes from cryptococcal meningitis following treatment induction with 800 mg oral fluconazole in Blantyre, Malawi","volume":"8","author":"Rothe C","year":"2013","journal-title":"PLoS One."},{"issue":"10","key":"ref46","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1086\/592690","article-title":"Cryptococcosis in solid organ transplant recipients: current state of the science","volume":"47","author":"Singh N","year":"2008","journal-title":"Clin Infect Dis."},{"key":"ref47","first-page":"9","article-title":"Cryptococcal antigen screening in asymptomatic HIV-infected antiretroviral Na\u00efve patients in Cameroon and evaluation of the new semi-quantitative Biosynex CryptoPS Test","volume":"13","author":"Temfack E","year":"2018","journal-title":"Front Microbiol."},{"issue":"10","key":"ref48","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1128\/JCM.30.10.2544-2550.1992","article-title":"Evaluation of a monoclonal antibody-based latex agglutination test for diagnosis of cryptococcosis: comparison with two tests using polyclonal antibodies","volume":"30","author":"Temstet A","year":"1992","journal-title":"J Clin Microbiol."},{"issue":"1","key":"ref49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM199707033370103","article-title":"Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group","volume":"337","author":"van der Horst CM","year":"1997","journal-title":"N Engl J Med."},{"issue":"5","key":"ref50","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1093\/cid\/cix872","article-title":"High cryptococcal antigen titers in blood are predictive of subclinical cryptococcal meningitis among HIV-infected patients","volume":"66","author":"Wake RM","year":"2018","journal-title":"Clin Infect Dis."},{"key":"ref51","series-title":"Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy","year":"2017"},{"key":"ref52","series-title":"Guidelines for the diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children","year":"2018"},{"key":"ref53","series-title":"Rapid Advice: diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children","year":"2011"},{"issue":"7","key":"ref54","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1128\/AAC.00212-12","article-title":"The antidepressant sertraline provides a promising therapeutic option for neurotropic cryptococcal infections","volume":"56","author":"Zhai B","year":"2012","journal-title":"Antimicrob Agents Chemother."}],"container-title":["Mem\u00f3rias do Instituto Oswaldo Cruz"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/mioc\/v113n7\/0074-0276-mioc-0074-02760180050.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T04:59:02Z","timestamp":1661144342000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0074-02762018000700207&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,7]]},"references-count":54,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018]]}},"alternative-id":["S0074-02762018000700207"],"URL":"https:\/\/doi.org\/10.1590\/0074-02760180050","relation":{},"ISSN":["1678-8060","0074-0276"],"issn-type":[{"value":"1678-8060","type":"electronic"},{"value":"0074-0276","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5,7]]}}}